Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Malignant tumors of the eye are uncommon, yet of great importance due to their effect on the patient's life and vision. The most common primary intraocular tumors are retinoblastoma in children and uveal melanoma in adults. The most common periocular tumor is basal cell carcinoma in eyelids. Management of these tumors can be challenging. On one hand, it can be difficult to control intraocular tumors like retinoblastoma or uveal melanoma from spreading out of the eye which will decrease the chances of survival of these patients. On the other hand, in eyelid tumors that have spread into the ocular tissue, this can make it surgically non-removable. In the past decades, many new treatments, local and systemic, have emerged with the main aim of saving the patient's life, as well as saving the globe of the eye and when possible, the vision. This has improved the overall survival of these patients. In this article, we reviewed the latest advances in the treatment of these tumors in the past decade. In addition, we reviewed the advances in the management and treatment of conjunctival melanoma, a very rare but lethal malignant tumor of the eye.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!